EDIT
Editas Medicine Inc
$3.21
0.01 (0.31%) Today
— up— down
Market Cap
$491M+46.8%
Revenue (TTM)
$66.33M+8.0%
Net Income (TTM)
$-205,106,496
$-205,106,496EPS (TTM)
-1.22
-1.22Shares Out
167.79M
167.79MOpen
$3.19
$3.19Previous Close
$3.20
$3.20Day Range
$3.11 – $3.27
$3.11 – $3.2752-Week Range
$1.66 – $4.54
$1.66 – $4.54Beta
2.16
2.16Volume
755.26K
755.26KAvg Volume
2.17M
2.17MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout EDIT
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Related
News
Trump administration expands list of graduate degrees subject to higher borrowing limits
CNBC · 36m ago
We're selling some shares of a parabolic mover, more than tripling our money
CNBC · 1h ago
Uncertainty over Qatar diplomacy clouds prospects for US-Iran deal - Reuters
Reuters · 1h ago
Wall St set for strongest quarter in years as risk appetite holds despite US-Iran war - Reuters
Reuters · 1h ago
Ex-Google recruiter: The No. 1 resume 'red flag' that makes hiring managers stop reading—and how to fix it
CNBC · 1h ago